Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0452 Transporter Info | ||||
Gene Name | SLC6A2 | ||||
Transporter Name | Sodium-dependent noradrenaline transporter | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
MYC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A2 gene in embryonic stem cells condition | [1] | ||||
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Myc proto-oncogene protein (MYC) has been reported to bind to the transcription of SLC6A2 gene in embryonic stem cells condition, which leads to an affected expression of the drug transporter Sodium-dependent noradrenaline transporter. | |||||
Class1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TFAP2A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A2 gene in health condition | [2] | ||||
TF Protein Name |
Transcription factor AP-2-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor AP-2-alpha (TFAP2A) has been reported to bind to the transcription of SLC6A2 gene in health condition, which leads to an affected expression of the drug transporter Sodium-dependent noradrenaline transporter. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
AR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A2 gene in prostate cancer condition | [3] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC6A2 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Sodium-dependent noradrenaline transporter. | |||||
NR3C1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A2 gene in brain neuroblastoma condition | [4] | ||||
TF Protein Name |
Glucocorticoid receptor | Transcription Factor Info | ||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human neuroblastoma cells (SK-N-BE(2)-M17) | |||||
Detailed Description |
Glucocorticoid receptor (NR3C1) has been reported to activate the transcription of SLC6A2 gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter Sodium-dependent noradrenaline transporter. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
SCRT1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC6A2 gene in attention deficit hyperactivity disorder condition | [5] | ||||
TF Protein Name |
Transcriptional repressor scratch 1 | Transcription Factor Info | ||||
Studied Phenotype |
Attention deficit hyperactivity disorder [ICD11: 6A05] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human attention-deficit hyperactivity disorder cell isolates | |||||
Detailed Description |
Transcriptional repressor scratch 1 (SCRT1) has been reported to repress the transcription of SLC6A2 gene in attention deficit hyperactivity disorder condition, which leads to a decreased expression of the drug transporter Sodium-dependent noradrenaline transporter. | |||||
SNAI2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC6A2 gene in attention deficit hyperactivity disorder condition | [5] | ||||
TF Protein Name |
Zinc finger protein SNAI2 | Transcription Factor Info | ||||
Studied Phenotype |
Attention deficit hyperactivity disorder [ICD11: 6A05] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human attention-deficit hyperactivity disorder cell isolates | |||||
Detailed Description |
Zinc finger protein SNAI2 (SNAI2) has been reported to repress the transcription of SLC6A2 gene in attention deficit hyperactivity disorder condition, which leads to a decreased expression of the drug transporter Sodium-dependent noradrenaline transporter. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
HOXA5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A2 gene in brain neuroblastoma condition | [6] | ||||
TF Protein Name |
Homeobox protein Hox-A5 | Transcription Factor Info | ||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human neuroblastoma cells (SK-N-BE(2)-C) | |||||
Detailed Description |
Homeobox protein Hox-A5 (HOXA5) has been reported to activate the transcription of SLC6A2 gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter Sodium-dependent noradrenaline transporter. | |||||
PHOX2A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A2 gene in brain neuroblastoma condition | [6] | ||||
TF Protein Name |
Paired mesoderm homeobox protein 2A | Transcription Factor Info | ||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human neuroblastoma cells (SK-N-BE(2)-C) | |||||
Detailed Description |
Paired mesoderm homeobox protein 2A (PHOX2A) has been reported to activate the transcription of SLC6A2 gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter Sodium-dependent noradrenaline transporter. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
FOXO3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A2 gene in DLD1 condition | [7] | ||||
TF Protein Name |
Forkhead box protein O3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Forkhead box protein O3 (FOXO3) has been reported to activate the transcription of SLC6A2 gene in DLD1 condition, which leads to an increased expression of the drug transporter Sodium-dependent noradrenaline transporter. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A2 gene in megakaryocytes condition | [8] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) has been reported to bind to the transcription of SLC6A2 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Sodium-dependent noradrenaline transporter. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
RUNX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A2 gene in prostate cancer condition | [9] | ||||
TF Protein Name |
Runt-related transcription factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Runt-related transcription factor 2 (RUNX2) has been reported to activate the transcription of SLC6A2 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Sodium-dependent noradrenaline transporter. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SMAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A2 gene in human embryonic stem cells (hESCs) condition | [10] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to activate the transcription of SLC6A2 gene in human embryonic stem cells (hESCs) condition, which leads to an increased expression of the drug transporter Sodium-dependent noradrenaline transporter. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.